Compare Baxter International Inc (BAX) vs Sanofi SA (SNY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Baxter International Inc vs Sanofi SA — how do they compare? Baxter International Inc trades at $27.03 (market cap $13.93B), while Sanofi SA trades at $43.81 (market cap $104.30B). The key difference: Sanofi SA is far larger — about 7.5× Baxter International Inc's market cap, and Sanofi SA pays the higher dividend (5.53%). Which is the better fit depends on your goals.
| BAX | SNY | |
|---|---|---|
Market Cap | $13.93B | $104.30B |
Sector | Health | Health |
52-Week High | $28.35 | $52.34 |
52-Week Low | $15.80 | $41.33 |
Enterprise Value | $21.45B | $124.19B |
Dividend Yield | 0.15% | 5.53% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Baxter International Inc
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.
Read more on BAX →About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →
